AI-Driven Diabetic Retinopathy Screening Market to Reach USD 2.22 Billion by 2033 at 21% CAGR | North America Leads with 40% Share

The AI‐Driven Diabetic Retinopathy Screening Market was valued at USD 0.4 billion in 2024, rising to USD 0.48 billion in 2025, and is projected to reach USD 2.22 billion by 2033, expanding at a CAGR of 21% during the forecast period from 2026 to 2033. This rapid growth is driven by the rising global prevalence of diabetes and associated retinal complications, highlighting the urgent need for early detection to prevent vision loss. AI-based screening solutions leveraging deep learning algorithms on fundus and other retinal imaging modalities offer accurate, scalable, and efficient diagnostic capabilities, enabling large‐scale population screening programs and improved patient outcomes.

Clinical validation and real-world performance are fueling adoption of these AI-driven systems. Multiple independent studies demonstrate that AI algorithms achieve diagnostic accuracy comparable to expert human graders, with pooled sensitivities exceeding 90% and pooled specificities reaching 85-90% for referable diabetic retinopathy detection. Recent momentum includes integration of AI screening into teleophthalmology networks, regulatory approvals for autonomous diagnostic platforms, and partnerships between healthcare providers and AI technology firms to expand access in underserved regions. These developments are positioning AI-driven diabetic retinopathy screening as a critical tool for proactive eye care, population health management, and scalable intervention against preventable blindness worldwide.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/ai-driven-diabetic-retinopathy-screening-market?sai-v

AI-Driven Diabetic Retinopathy Screening Market refers to the industry focused on developing and deploying artificial intelligence-based imaging and diagnostic solutions that enable early detection, assessment, and monitoring of diabetic retinopathy to support timely clinical intervention and vision preservation.

Key Developments

✅ February 2026: In the United States and global ophthalmology markets, Google Health expanded validation studies for its AI-based diabetic retinopathy screening model to include diverse retinal imaging datasets, strengthening evidence for broader clinical deployment in primary and specialist care settings.

✅ January 2026: In Europe (United Kingdom and Germany), Topcon Healthcare announced regulatory approval and commercial launch of its AI-integrated diabetic retinopathy screening software bundled with advanced retinal cameras for use in ophthalmology clinics and population screening programs.

✅ December 2025: In North America and Asia Pacific, Zeiss (Carl Zeiss Meditec) introduced upgraded AI-enabled fundus imaging analytics for diabetic retinopathy detection that integrates with electronic health record systems to streamline referral pathways and follow-up care.

✅ November 2025: In India, Forus Health reported expanded implementation of its AI-based diabetic retinopathy detection platform across eye care centers and public health screening initiatives, enhancing early identification in community settings.

✅ October 2025: In Europe and the United States, IDx Technologies updated its autonomous AI screening software for diabetic retinopathy to improve diagnostic sensitivity and operational workflow for primary care and optometry practices.

✅ September 2025: Across global digital eye care markets, healthcare providers and screening programs increased adoption of AI-driven diabetic retinopathy solutions as part of broader tele-ophthalmology and preventive care initiatives to reduce vision loss from diabetes.

Key Players
Eyenuk, Inc. | Digital Diagnostics Inc. | AEYE Health | Others

Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=ai-driven-diabetic-retinopathy-screening-market?sai-v
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K

Market Drivers

Rising Global Diabetes Prevalence: Increasing number of diabetic patients worldwide is driving urgent need for early and scalable retinopathy screening solutions.

Need for Early Detection to Prevent Vision Loss: AI based image analysis enables rapid identification of retinal abnormalities, improving treatment outcomes and reducing blindness risk.

Shortage of Ophthalmologists and Screening Infrastructure: Automated screening tools support primary care and remote settings where specialist access is limited.

Growth of Teleophthalmology and Digital Health: Integration with remote imaging devices and cloud platforms is expanding screening coverage in underserved regions.

Supportive Public Health Screening Programs: Government initiatives promoting routine diabetic eye screening are accelerating adoption of AI enabled solutions.

Industry Developments

Regulatory Cleared Autonomous AI Screening Systems: Vendors are launching clinically validated AI platforms capable of detecting diabetic retinopathy without specialist interpretation.

Integration with Retinal Imaging Devices and EHRs: Seamless connectivity with fundus cameras and health record systems enables efficient workflow and data management.

Advancements in Deep Learning Accuracy and Explainability: Improved algorithms provide higher diagnostic sensitivity along with transparent clinical decision support.

Expansion of Cloud Based Screening Services: Scalable deployment models allow mass population screening and centralized analysis.

Strategic Partnerships with Healthcare Providers: Collaborations with hospitals, clinics, and public health agencies are accelerating real world implementation.

Regional Insights

North America - Holds 40% share: Strong diabetes awareness, advanced healthcare IT infrastructure, and early regulatory approvals drive leadership.

Europe - Holds 27% share: Organized screening programs, supportive regulations, and growing digital health adoption sustain growth.

Asia Pacific - Holds 26% share: Large diabetic population, expanding telemedicine, and government backed screening initiatives accelerate demand.

Latin America - Holds 4% share: Improving access to eye care and digital diagnostics supports gradual adoption.

Middle East and Africa - Holds 3% share: Rising diabetes burden and increasing healthcare modernization contribute to early stage market expansion.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/ai-driven-diabetic-retinopathy-screening-market?sai-v

Key Segments

By Component
Software holds a dominant share driven by widespread deployment of AI algorithms, cloud based analytics platforms, and automated image interpretation tools that enable rapid and accurate diabetic retinopathy detection. Hardware components, including fundus cameras and imaging devices, maintain significant importance as essential infrastructure for high quality retinal image acquisition. Services are expanding steadily through implementation, integration, training, and ongoing technical support that ensure effective clinical adoption and workflow optimization.

By Screening Modality
Point of care screening represents a leading segment supported by increasing demand for rapid diagnosis in primary care settings, pharmacies, and community health programs. Tele screening is growing rapidly as remote image capture and AI based analysis improve accessibility in rural and underserved regions. Hospital based screening continues to maintain steady adoption for comprehensive ophthalmic evaluation and specialist referral pathways.

By Disease Severity Classification
Mild and moderate diabetic retinopathy detection accounts for a significant share due to strong emphasis on early diagnosis and timely intervention to prevent vision loss. Severe non proliferative and proliferative diabetic retinopathy segments are gaining attention as AI tools improve identification of high risk patients requiring urgent treatment. Diabetic macular edema screening also represents an important category given its direct association with vision impairment and need for prompt clinical management.

By Imaging Technology
Fundus photography dominates the market driven by cost effectiveness, wide clinical acceptance, and compatibility with AI based automated analysis. Optical coherence tomography is expanding steadily due to high resolution cross sectional retinal imaging that enhances detection of macular edema and disease progression. Other imaging technologies, including ultra widefield imaging, are emerging to provide broader retinal visualization and improved diagnostic accuracy.

By End User
Hospitals and ophthalmology clinics hold the largest share supported by advanced diagnostic infrastructure, specialist expertise, and high patient screening volumes. Diagnostic centers and teleophthalmology providers are expanding rapidly as AI enabled workflows increase screening capacity and geographic reach. Primary care settings and community health programs are increasingly adopting AI driven screening solutions to support early detection, preventive care, and reduced burden of diabetes related vision loss across populations.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.